For an updated comparison, the cagrilintide vs retatrutide comparison covers the head-to-head data
He noted that it can take 10 or more years to develop a new drug and often drugs fail
For everyone else, the lean-chasers and the founders judging themselves against launch videos, the honest answer is that nobody has studied you, and the strongest tool is rarely the right one for the smallest job
Postprandial hypoglycaemia after gastric bypass in type 2 diabetes: pathophysiological mechanisms and clinical implications The authors conclude "that post-bypass PPHG occurs frequently in individuals with a history of type 2 diabetes, often without warning symptoms, and expose its complex pathogenetic mechanisms, revealing potential therapeutic targets." In Diabetologia: The underlying mechanisms of postbariatric hypoglycemia are multifactorial and related to the anatomic reconfiguration of the gastrointestinal tract causing accelerated intestinal nutrient delivery and transit, leading to augmented glucose absorption and exaggerated release of insulinotropic GLP-1, which together ensue severe hyperinsulinaemia (insulin overshoot), leading to postprandial hypoglycemia 1 to 3 h after meal intake
Wegovy, a version of semaglutide specifically for weight loss, became available in 2021
